rs568139514
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_144672.4(OTOA):āc.3377T>Cā(p.Leu1126Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 150,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_144672.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOA | NM_144672.4 | c.3377T>C | p.Leu1126Pro | missense_variant | 29/29 | ENST00000646100.2 | NP_653273.3 | |
OTOA | NM_001161683.2 | c.3140T>C | p.Leu1047Pro | missense_variant | 24/24 | NP_001155155.1 | ||
OTOA | NM_170664.3 | c.2405T>C | p.Leu802Pro | missense_variant | 19/19 | NP_733764.1 | ||
OTOA | XM_011545748.3 | c.2246T>C | p.Leu749Pro | missense_variant | 18/18 | XP_011544050.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOA | ENST00000646100.2 | c.3377T>C | p.Leu1126Pro | missense_variant | 29/29 | NM_144672.4 | ENSP00000496564.2 |
Frequencies
GnomAD3 genomes AF: 0.000193 AC: 29AN: 150466Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.000245 AC: 61AN: 249268Hom.: 0 AF XY: 0.000282 AC XY: 38AN XY: 134864
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000245 AC: 356AN: 1454618Hom.: 0 Cov.: 31 AF XY: 0.000249 AC XY: 180AN XY: 723760
GnomAD4 genome AF: 0.000193 AC: 29AN: 150588Hom.: 0 Cov.: 27 AF XY: 0.000150 AC XY: 11AN XY: 73314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 16, 2013 | The Leu1126Pro variant in OTOA has been previously identified in two individuals with hearing loss by our laboratory, however neither patient carried a second O TOA variant and one individual had pathogenic variants in another gene that expl ained the hearing loss. Computational analyses (biochemical amino acid propertie s, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support f or or against an impact to the protein. In summary, additional data is needed to determine the clinical significance of this variant. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.3377T>C (p.L1126P) alteration is located in exon 28 (coding exon 28) of the OTOA gene. This alteration results from a T to C substitution at nucleotide position 3377, causing the leucine (L) at amino acid position 1126 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Hearing impairment Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Department of Otolaryngology ā Head & Neck Surgery, Cochlear Implant Center | Apr 12, 2021 | PM2_Supporting, BP4_Supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at